Allergy Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Allergy Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Allergy Therapeutics's Price has grown from £0.00 to £0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach £0.00 – an increase of 100.00%. Over the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GWPH Stock Forecast | GW Pharmaceuticals | - |
6
|
$219.00 | Buy/Sell | $188.33 | 5.14% |
| ABCM Stock Forecast | Abcam | - |
18
|
$23.99 | Buy/Sell | $19.25 | -67.15% |
| GNS Stock Forecast | Genus | Buy |
18
|
£17.36 | Buy/Sell | £33.09 | 74.54% |
| AUTL Stock Forecast | Autolus Therapeutics | Buy |
6
|
$4.00 | Buy/Sell | $9.23 | 175.00% |
| BCYC Stock Forecast | Bicycle Therapeutics | Outperform |
7
|
$22.73 | Buy/Sell | $44.47 | 89.18% |
Allergy Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Allergy Therapeutics's Revenue has fallen from £78.20M to £59.59M – a 23.80% decrease. Next year, analysts are expecting Revenue to reach £65.70M – an increase of 10.25%. Over the next seven years, the forecast is for Revenue to grow by 18.08%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SLN Stock Forecast | Silence Therapeutics | Outperform |
7
|
$21.61 | Buy/Sell | $42.75 | 131.37% |
| CMPS Stock Forecast | COMPASS Pathways | Buy |
3
|
$7.94 | Buy/Sell | $45.43 | 246.35% |
| MREO Stock Forecast | Mereo BioPharma Group | Buy |
5
|
$2.74 | Buy/Sell | $3.46 | 73.36% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ADAP Stock Forecast | Adaptimmune Therapeutics | Outperform |
7
|
$1.08 | Buy/Sell | $3.60 | 85.19% |
| ORTX Stock Forecast | Orchard Therapeutics | - |
7
|
$16.70 | Buy/Sell | $16.00 | -100.00% |
| BVXP Stock Forecast | Bioventix PLC |
18
|
£44.50 | Buy/Sell | £44.00 | 32.58% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NIOX Stock Forecast | NIOX Group Plc | Outperform |
6
|
£0.67 | Buy/Sell | £0.76 | 14.93% |
| OXB Stock Forecast | Oxford Biomedica | Outperform |
10
|
£2.29 | Buy/Sell | £4.24 | 35.37% |
| HZD Stock Forecast | Horizon Discovery Group | - |
3
|
£0.00 | Buy/Sell | £0.00 | 0.00% |
Allergy Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Allergy Therapeutics's EBITDA has gone down from £7.14M to £-33.08M – a 563.31% drop. In the next year, analysts believe that EBITDA will reach £-44.93M – an increase of 35.83%. For the next seven years, the forecast is for EBITDA to grow by 26.35%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ETX Stock Forecast | e-therapeutics |
9
|
£0.16 | Buy/Sell | £0.16 | -100.00% | |
| SCLP Stock Forecast | Scancell Holdings | Buy |
4
|
£0.10 | Buy/Sell | £0.23 | 130.00% |
| BRNS Stock Forecast | Barinthus Biotherapeutics | Outperform |
2
|
$2.50 | Buy/Sell | $8.80 | 180.00% |
Allergy Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Allergy Therapeutics's EBIT has fallen from £4.99M to £-35.19M – a 805.21% decrease. In the next year, analysts believe that EBIT will reach £-46.20M – an increase of 31.30%. For the next seven years, experts predict that Allergy Therapeutics's EBIT will grow at a rate of 18.98%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| REDX Stock Forecast | Redx Pharma Plc | Buy |
9
|
£0.09 | Buy/Sell | £1.25 | 1344.44% |
| DDDD Stock Forecast | 4D pharma | - |
7
|
£0.36 | Buy/Sell | £0.00 | -100.00% |
| NANO Stock Forecast | Nanoco Group |
8
|
£0.20 | Buy/Sell | £0.09 | 200.00% |
Allergy Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Allergy Therapeutics's EPS has grown from £-0.08 to £0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach £0.00 – an increase of 100.00%. Over the next six years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DNL Stock Forecast | Diurnal Group | - |
0
|
£0.27 | Buy/Sell | £0.69 | -100.00% |
| TLSA Stock Forecast | Tiziana Life Sciences Ltd | Buy |
2
|
$0.52 | Buy/Sell | $5.00 | 363.46% |
| TRX Stock Forecast | Tissue Regenix Group |
5
|
£0.62 | Buy/Sell | £1.20 | 93.55% |
.jpg)